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The first case of squamous cell carcinoma of the vulva in a 
patient with androgen insensitivity syndrome is described. D IWO 
Academic Press, Inc. 
INTRODUCTION 
The complete form of androgen insensitivity syndrome 
(testicular feminization) occurs in a 46,XY karyotype 
with a mutant X-linked recessive gene that is responsible 
for the androgen intracellular receptor [l]. An individual 
with androgen insensitivity syndrome is a male pseu- 
dohermaphrodite. Phenotypic characterizations include 
scanty or absent axillary and pubic hair, slight vulvar 
hair, a rudimentary or absent vagina, euchnoidal struc- 
ture, and breasts with small nipples and pale areolae. 
Cancers, in association with androgen insensitivity 
syndrome, have been thoroughly investigated. Neo- 
plasms arising from the gonads and the neovagina have 
been reported. The following is the first report of squa- 
mous cell carcinoma of the vulva in a patient with an- 
drogen insensitivity syndrome. 
CASE REPORT 
A 47-year-old patient with androgen insensitivity syn- 
drome presented to the University of Michigan gyne- 
cology clinic with complaints of vaginal burning and dis- 
comfort. She had not undergone a Papanicolaou smear 
for approximately 6 years. A “hernia repair” on the right 
side had been performed at age 5 at an outside hospital. 
A 5 x 3 x 1.5cm mass was removed from the right 
inguinal area. Microscopic analysis revealed loose con- 
nective tissue with a lining of endothelial cells. The tissue 
was arranged in formations resembling embryonic tes- 
ticular tissue. 
She presented to the gynecology clinic initially at age 
22 with a 4.0-cm mass in the left groin, persistent amen- 
orrhea, and a vaginal canal with a depth of 1.5 cm. 
Physical examination revealed normal breast develop- 
ment. There was a lack of axillary and pubic hair. No 
pelvic organs were palpated on rectal examination. A 
buccal smear revealed a negative six chromatin pattern 
consistent with a 46,XY karyotype. A 24-hr gonadotropin 
was 54.0 Mouse Uterine Units (normal, 6.0-48.0 Mouse 
Uterine Units). The 24-hr 17-ketosteroids were 6.5 mg 
(normal male values, 3.5-15.0 mg; normal female values, 
2.5-8.5 mg). The 24-hr 17-hydroxysteroids were 3.8 mg 
(normal, 5.0-10.0 mg). Testicular feminization was 
diagnosed. 
The patient’s family history was significant for a sister 
with androgen insensitivity syndrome who presented at 
age 19 with persistent amenorrhea and vaginal agenesis 
requiring vaginal reconstruction. 
At age 22, the patient underwent a split-thickness skin 
graft vaginoplasty and excision of the left groin mass. 
Pathological examination revealed testicular tissue with 
marked interstitial cell hyperplasia, tubular sclerosis, and 
aspermatogenesis with preservation of Sertoli cells. 
At age 47, the patient presented with complaints of a 
clear vaginal discharge and vaginal burning for over 4 
months. Physical examination revealed a 3.0 x 3.0-cm 
indurated, friable lesion on the medial aspect of the right 
vulva, extending into the neovagina and distal urethra. 
Groin nodes were clinically negative. A vulvar biopsy 
was performed, revealing invasive keratinizing squamous 
cell carcinoma. Preoperative evaluation included a nor- 
mal chest X ray, pelvic ultrasound, and lymphangiogram. 
This lesion was classified as a stage III (T3NOMO) car- 
cinoma of the vulva. 
The patient underwent a radical vulvectomy, bilateral 
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groin lymph node dissection, and a partial resection of 
the neovagina and distal urethra. A bilateral pelvic lymph 
node dissection was performed since the neovagina also 
was involved. A moderately differentiated invasive squa- 
mous cell carcinoma of the vulva was identified. All of 
the groin and pelvic lymph nodes were negative for neo- 
plasm. No angiolymphatic invasion was present and the 
surgical margins were clear. Blot hybridization methods 
were used to screen for the presence of human papil- 
lomavirus (HPV) [2]. No detectable HPV DNA se- 
quences were found in the excised tissue screened for 
HPV types 6, 11, 16, 18, and 31. The patient’s postop- 
erative course was without complications. 
DISCUSSION 
The male pseudohermaphrodite is a phenotypic female 
with an XY karyotype and testicular gonads. Androgen 
insensitivity syndrome is the most common form of male 
pseudohermaphroditism. Approximately two-thirds of 
the androgen insensitivity syndrome cases are familial 
[3]. About one-half of the male children of an individual 
with this genetic abnormality are affected [4]. The fre- 
quency of androgen insensitivity syndrome is estimated 
to vary from 1 in 20,000 to 1 in 64,000 male births. Ten 
percent of all cases of primary amenorrhea are secondary 
to androgen insensitivity syndrome [5]. 
In patients with androgen insensitivity syndrome, 
there is an increased incidence of malignant germ cell 
neoplasms developing after puberty in the gonads. Go- 
nadal neoplasms reported in association with androgen 
insensitivity syndrome include seminomas [6,7], gonad- 
blastomas [8], malignant teratomas [6,9], embryonal 
cell carcinomas [9,10], testicular tubular adenomas or 
Sertoli cell tumors [7,11], “alveolar carcinomas” [6], 
dysgerminomas, arrhenoblastomas [ 121, and heman- 
gioendotheliomas [ 131. The risk of neoplasia is low before 
age 2.5 [12]. The usual recommendation is to leave the 
gonads in place in patients with androgen insensitivity 
syndrome until puberty is completed, to allow normal 
sexual maturation. The patient is started on hormonal 
replacement therapy following surgery. An investigation 
to evaluate carcinomatous changes in patients prior to 
puberty was performed by Mtiller and Skakkebaek. In- 
tratubular neoplasia was found in the testicles of two 
prepubertal (youngest age, 2 months) and one pubertal 
patient out of 12 with the androgen insensitivity syn- 
drome. It is notable that all three of these patients with 
intratubular neoplasia had incomplete androgen insen- 
sitivity syndrome. Mtiller and Skakkebaek recommend 
testicular biopsy in all patients with androgen insensi- 
tivity syndrome as soon as the syndrome is diagnosed. 
If carcinoma in situ is found, immediate orchidectomy 
is indicated. They recommend a repeat biopsy at puberty 
if orchidectomy is not performed [14]. Hurt er al. de- 
scribe a 14-year-old girl with complete androgen insen- 
sitivity syndrome who was found to have a left abdom- 
inopelvic mass consistent with a seminoma. A right 
adnexal mass was an immature testis that contained foci 
of intratubular seminoma. Two suspicious lymph nodes 
were sampled and found to contain metastatic disease. 
Their review of the literature found three other teenagers 
with androgen insensitivity syndrome who developed 
gonadal malignancies [15]. These studies suggest the 
need to reevaluate the postponement of prophylactic 
gonadectomy until pubertal growth and feminization are 
completed. 
Although these patients are at risk for developing go- 
nadal neoplasms, malignancies arising in the lower gen- 
ital tract are unusual. Duckler, in 1972, reported a mod- 
erately differentiated squamous cell carcinoma that de- 
veloped in the neovagina of a patient with a “presumed” 
androgen insensitivity syndrome [ 161. The patient pre- 
sented with vaginal bleeding from an artificial vagina 
created at age 17. The patient was phenotypically female 
with a complete loss of axillary hair, clitoral hypertro- 
phy, and absence of a vagina. Urinary steroids, chro- 
matin blood types, plasma levels of 17-ketosteroids, and 
chromosomal analysis were not obtained. At laparotomy 
no internal female genitalia were present. The right side 
contained a normal testicle and the left side had a sper- 
matocele. She was diagnosed with squamous cell car- 
cinoma of the vagina and rectum 19 years following a 
vaginal reconstruction which used a split-thickness skin 
graft taken from the lateral aspect of the thigh. 
The present case demonstrates that malignancies may 
also involve the vulva. It is interesting to note that this 
malignancy occurred approximately 20 years before the 
mean age for invasive squamous cell carcinoma of the 
vulva. In addition, the patient’s past medical history was 
not significant for diabetes mellitus, obesity, granuloma- 
tous disease, or hypertension, which are findings often 
associated with patients who have carcinoma of the 
vulva. Another finding noted in conjunction with carci- 
noma of the vulva is the presence of human papilloma 
virus [I7]. As was previously mentioned, no HPV DNA 
sequences were detected when the tissue was examined 
for HPV types 6, 11, 16, 18, and 31. 
Did the vaginal reconstruction 25 years earlier play a 
role in the development of the carcinoma? There is a 
possibility that the squamous cell carcinoma arose in the 
neovaginal graft and spread to the vulva, although it is 
rarer for tumor to spread in this manner. In truth, the 
cause of the squamous cell carcinoma in this patient is 
unknown. The above case emphasizes that continued 
surveillance and gynecologic care are indicated for these 
individuals. 
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